ReportsWeb- Migraine Worldwide Market by Value, Drug Type, Ind

Migraine Worldwide Market by Value, Drug Type, Indication, Analysis
2017 and Forecast to 2021
ReportsWeb.com published “Migraine Market” from its database. The report covers the market
landscape and its growth prospects over the coming years. The report also includes a discussion
of the key vendors operating in this market.
Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is
one of the most common and most prevalent disabling neurological conditions, characterized
by episodes often called migraine attacks. They are quite different from regular headaches
which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might
cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional
challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine
attacks can cause significant pain for hours to days and can be so severe that the pain is
disabling. Migraine headache is typically throbbing, unilateral (one sided) , and is aggravated by
physical activity. It typically presents with additional symptoms in addition to headache pain,
including nausea, and sensitivity to light and/or sound.
For more information about this report: http://www.reportsweb.com/global-migraine-market-
industry-analysis-and-outlook-2017-2021
Depending on symptoms, migraine is broadly classified into two categories, Chronic and
Episodic. Migraines can be treated with two types of drugs: abortive and preventive. Abortive
medications are especially useful for people who have nausea or vomiting related to their
migraine, and they work quickly. Preventive treatment is considered if migraine occurs
frequently, typically more than one migraine per week, or if migraine symptoms are severe.
The global migraine market is set to experience favourable growth driven by factors such as
increasing female population & increasing cigarette consumption. Further, the scope of growth
for this market will be broadened by rising healthcare expenditure and accelerating economic
growth. However, growth of this budding market will be hindered by limitations of current
migraine therapies, regulatory challenges and high cost associated with migraine drugs.
The report "Global Migraine Market: Industry Analysis & Outlook (2017-2021) " analyses the
development of this market, with focus majorly on the U.S. market. The major trends, growth
drivers as well as issues being faced by the market are discussed in detail in this report. The four
major players: Amgen Inc., Eli Lilly and Company, Teva Pharmaceuticals & Alder
Biopharmaceuticals are being profiled along with their key financials and strategies for growth.